Menu

Recent Interviews

Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)

info@cleanlogistics.de

+49-4171-6791300

Interview Clean Logistics: Hydrogen challenge to Daimler + Co.


Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

info@krl.com.sg

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".


Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


19. May 2020 | 15:02 CET

Aphria, Aurora Cannabis, Canopy Growth, EXMceuticals - do not miss the entry!

  • Cannabis
Photo credits: pixabay.com

The nationwide and anonymous advertising format of Deutsche Post is called POSTAKTUELL and is published regularly in large print runs. The stack of advertising is wrapped in a foil and the practical added value for the recipient is the TV guide. The front of POSTAKTUELL is particularly eye-catching and anyone who advertises there will reach a lot of people. In the meantime, advertising for products and applications with active ingredients from the cannabis plant is already being done there. CBD reaches the general public and despite the Corona Pandemic, the industry's stocks are running in turnaround mode and have left the lows.

time to read: 1 minutes by Mario Hose
ISIN: CA05156X8843 , CA03765K1049 , CA1380351009 , CA30207T1049


 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


Natural ingredients with value

The active ingredients of the cannabis plant have a long history. For about ten years they have been experiencing a renaissance and the possibilities of herbal therapy are becoming increasingly important. Manufacturers of products are expanding their spectrum of use possibilities for health and well-being according to the desires and needs of their target groups. In addition to medical preparations, more and more cosmetic and modern lifestyle products with the CBD label are available. The trend in modern society is moving towards natural ingredients and this has been made possible by the legalisation of the cannabis plant.

New market with competitive pressure

Put simply, the origin of the recent cannabis movement started in Canada about ten years ago. This is also where the largest companies in the industry were established. With valuations beyond the billion-dollar mark, investors and entrepreneurs around the globe were attracted. Since then, many people have been trying their luck in the industry to get a slice of the pie in the growth market. After the never-ending hype of the cannabis industry, more than a year ago market participants and investors went into a kind of hangover mood. Too many companies need too much money to build up and profitability was not forthcoming.

Recovery phase makes stocks rise

After a cooling-down phase of the market and enormous price losses of the shares of the public companies, the countermovement now seems to be starting. A consolidation phase often has a healing effect and it can usually be worthwhile to spread the capital to be invested in order to be diversified in the industry. At a level of 4.70 CAD, the market value of Aphria is around CAD 1.25 billion. Aurora Cannabis has a market value of around CAD 1.56 billion at a share price of CAD 15.35. Canopy Growth is valued as a heavyweight at over CAD 7.83 billion with a stock price of CAD 22.33

Young company with potential

A young supplier with pure ingredients is EXMceuticals and is focused on the quality health care industry. With a share price of CAD 0.475, the company has a market value of CAD 17.36 million. EXMceuticals is based in Lisbon, Portugal, with its operational team and plans sales in the EU from there. The German company Symrise has set an example of success in the ingredients sector. At EUR 94.48, the company is now valued at over EUR 12.81 billion on the stock exchange.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

28. October 2021 | 12:04 CET | by André Will-Laudien

Canopy, Tilray, Sativa Wellness, Formycon - Finding the next cannabis rocket!

  • Cannabis

The big bull market in cannabis ran through 2018 and 2019, and then in 2020, the reality set in that only a fraction of states around the world will implement general licensing for hemp. The newly elected federal parliament has its first constituent session these days. Climate change and investments in digital infrastructure are two of the most important topics in the coalition negotiations to form a new federal government. One topic that is not quite so high on the list of priorities, but is already causing a lot of excitement in the run-up, is the possible legalization of cannabis. The Greens and FDP have been advocating legal, regulated trade for some time. Of course, nothing has been decided yet, but the outgoing federal government's drug commissioner, Daniela Ludwig of the CSU, already warns of the consequences. We take a look at important industry representatives.

Read

26. October 2021 | 11:37 CET | by Stefan Feulner

Tilray, Ayurcann, Aurora Cannabis, Canopy Growth - Sow first, then reap

  • Cannabis

After the hype around cannabis companies like Aurora Cannabis, Tilray and Canopy Growth in 2018, consolidation followed, and it continues. But the industry is moving mightily. Smaller companies disappeared from the price list, while big players expanded their market power through mergers and acquisitions for the next few years. The cannabis industry is predicted to grow tremendously in the future. The fantasy is fueled by government legalization plans in several states, including Germany.

Read

04. March 2021 | 09:16 CET | by Stefan Feulner

NanoRepro, EXMceuticals, Deutsche Telekom - The profiteers of the new world!

  • Cannabis

The world has changed since last year. The goal is to fight and contain the virus, which has destroyed our everyday life. In addition to the vaccine manufacturers such as BioNTech, AstraZeneca or Moderna, there are more and more new winners emerging from nowhere to become new stock market stars. Currently, the dominant topic, apart from the vaccination programs that are still hardly taking place in Germany, is the "national testing strategy." At the very least, this should enable a more regular and open life. Be there!

Read